A miR‐15a related polymorphism affects NSCLC prognosis via altering ERCC1 repair to platinum‐based chemotherapy

Platinum‐based chemotherapy is regarded as a preferential curative‐intent option for non‐small cell lung cancer (NSCLC), while the acquired drug resistance has become a major obstacle that limits its clinical application. Since the repair efficiency of tumour cells to platinum‐DNA adducts plays a cr...

Descripción completa

Detalles Bibliográficos
Autores principales: Xue, Ping, Zhang, Guopei, Zhang, Hongchao, Cui, Su, Zhang, Liang, Yu, Tao, Xiao, Mingyang, Li, Liuli, Lu, Xiaobo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9639052/
https://www.ncbi.nlm.nih.gov/pubmed/36181289
http://dx.doi.org/10.1111/jcmm.17566

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9639052/
https://www.ncbi.nlm.nih.gov/pubmed/36181289
http://dx.doi.org/10.1111/jcmm.17566

Ejemplares similares